Foot-and-mouth disease virus (FMDV) outer capsid proteins 1B, 1C and 1D contribute to the virus serotype distribution and antigenic variants that exist within each of the seven serotypes. This study presents phylogenetic, genetic and antigenic analyses of South African Territories (SAT) serotypes prevalent in sub-Saharan Africa. Here, we show that the high levels of genetic diversity in the P1-coding region within the SAT serotypes are reflected in the antigenic properties of these viruses and therefore have implications for the selection of vaccine strains that would provide the best vaccine match against emerging viruses. Interestingly, although SAT1 and SAT2 viruses displayed similar genetic variation within each serotype (32 % variable amino acids), antigenic disparity, as measured by r 1 -values, was less pronounced for SAT1 viruses compared with SAT2 viruses within our dataset, emphasizing the high antigenic variation within the SAT2 serotype. Furthermore, we combined amino acid variation and the r 1 -values with crystallographic structural data and were able to predict areas on the surface of the FMD virion as antigenically relevant. These sites were mostly consistent with antigenic sites previously determined for types A, O and C using mAbs and escape mutant studies. Our methodology offers a quick alternative to determine antigenic relevant sites for FMDV field strains.
INTRODUCTION
Foot-and-mouth disease (FMD) is widely considered an economically important disease of livestock, and is a compulsory OIE notifiable disease as it remains a global threat to national and international trade in livestock and livestock products. In 2010, outbreaks have occurred in South America, Asia, the Middle East and Africa (FMD Reference Laboratory Network Report, 2010) . FMD is of particular importance in Africa where the disease is endemic and six of the seven immunologically distinct serotypes occur (Thomson, 1994; Vosloo et al., 2002) . Although foot-and-mouth disease virus (FMDV) causes a clinically indistinguishable vesicular disease in clovenhoofed animals, the seven serotypes display different geographical distributions and epidemiology (Samuel & Knowles, 2001; Bastos et al., 2001 Bastos et al., , 2003a Knowles & Samuel, 2003; Bronsvoort et al., 2004) .
The South African Territories (SAT) types 1, 2 and 3 are confined to sub-Saharan Africa, although incursions into the Middle East by SAT1 (1961-1965 and 1970) and SAT2 (1990 and viruses have been recorded (Ferris & Donaldson, 1992; Bastos et al., 2001 ; Records of the OIE). The SAT3 serotype has a restricted distribution and essentially occurs only in southern Africa (Bastos et al., 2003b) , Asia-1 is restricted to Asia and the Middle-East (Ansell et al., 1994) , while serotypes A and O occur globally (Samuel & Knowles, 2001 ). The distribution of FMD samples received from Africa from 2000 to 2010 revealed that the majority of outbreaks (41 %) were caused by serotype SAT2 viruses. The prevalence of SAT1 and type O viruses was similar with 19 and 23 %, respectively. Outbreaks caused by type A viruses were identified for 15 % of the reported cases. In contrast, SAT3 viruses caused only two outbreaks during this period in the Democratic Republic of Congo and South Africa, respectively, whereas type C was only detected in Kenya in 2004 (Annual OIE/FAO FMD Reference Laboratory Network Reports; Records of the OIE). Eradication of the disease from the African continent is unlikely due to the presence of large numbers of the free-living maintenance host, the African buffalo (Syncerus caffer). These animals provide a potential source of infection for domestic livestock and wildlife (Dawe et al., 1994; Bastos et al., 2000; Vosloo & Thomson, 2004) and pose a constant threat to susceptible livestock (Vosloo & Thomson, 2004) in the rest of the world.
Persistently infected buffalo are the ideal hosts to maintain co-infection of different virus serotypes and to facilitate antigenic and molecular evolution of the virus (Condy et al., 1985; Esterhuysen, 1994; Vosloo et al., 1996 Vosloo et al., , 2006 . Genetic variation results from changes to the viral genome as a consequence of the high mutation rate of the virus. Therefore, the genetic diversity will most likely be reflected in antigenic differences. The outer capsid proteins are directly involved in antigenicity since 30-50 % of their residues are exposed on the virion surface, many of which constitute neutralizing epitopes (Acharya et al., 1989; Logan et al., 1993; Lea et al., 1995; Mateu, 1995; Usherwood & Nash 1995) . Although several antigenic sites have been identified for A and O serotypes (Xie, et al., 1987; Thomas et al., 1988; Baxt et al., 1989; Bolwell et al., 1989; McCahon et al., 1989; Kitson et al., 1990; Saiz et al., 1991; Crowther et al., 1993a) , a dearth of knowledge exists for the epitopes of the SAT types. Identification of those residues that comprise the antigenic determinants of the SAT viruses will allow the identification of those changes in outbreak strains that may cause escape from protection afforded by the vaccine. Once such epitopes for the SAT types have been identified, it may be possible to predict the protection afforded by a vaccine against a specific outbreak virus.
The SAT types display appreciably greater intratypic genomic and antigenic variation than the 'Euro-Asian' types (Vosloo et al., 1992 (Vosloo et al., , 1995 (Vosloo et al., , 1996 Esterhuysen, 1994; Bastos et al., 2001 Bastos et al., , 2003a . Even within a serotype, distinct genetic and antigenic variants exist in different geographical regions. This has implications for the control of the disease by vaccination, since it may render available vaccines less effective (Hunter, 1998) . Consequently, the ability to predict vaccine efficacy would be a valuable tool in an effective control strategy as control of FMD in Africa is essentially via strategic vaccination and restriction of animal movements.
Traditionally, the in vitro virus neutralization test (VNT) and statistically calculated r 1 -values are used to determine antigenic relationships between a vaccine strain and an outbreak virus (Rweyemamu et al., 1978) . Meanwhile molecular epidemiological techniques have offered the possibility of more detailed analyses of FMD epidemiology (Vosloo et al., 1992; Samuel & Knowles, 2001; Bastos et al., 2001 Bastos et al., , 2003a Knowles & Samuel, 2003) . We have investigated the genetic variation of the complete capsidcoding region of representative FMDV strains found in sub-Saharan Africa during a 28 year period from 1974 to 2002. Variable regions on the capsid proteins of SAT1 and SAT2 isolates were then combined with structural data and serological relatedness to identify possible epitopes that could be prone to antigenic variation in the SAT viruses.
RESULTS

Phylogenetic relationships and topotype diversity in sub-Saharan Africa
The minimum evolution phylogeny, based on P1 nucleotide sequences of representative SAT viruses that caused outbreaks across the African continent over the past 28 years, is indicated in Fig. 1 . The SAT viruses clustered according to serotype with high bootstrap support. The distribution of SAT3 serotype is limited to southern Africa. The five SAT3 isolates represented five of the six previously described topotypes. Three major virus lineages, which have evolved separately, exist within serotypes SAT1 and SAT2. The lineages clustered according to their geographical location (southern, western and eastern Africa) and are in agreement with the FMD topotype concept described for the European and SAT serotypes (Samuel & Knowles, 2001; Bastos et al., 2001 Bastos et al., , 2003a Knowles & Samuel, 2003) . Exceptions, however, were observed for SAT1 and SAT2, where isolates from East Africa, i.e. SAT2/KEN/08/99, SAT1/KEN/05/98 and SAT1/TAN/37/99, clustered in the southern topotypes (Fig. 1) , possibly due to historical movement of buffalo and livestock between the two regions (Bastos et al., 2001; Sangare et al., 2003) . Similarly, an isolate from Sudan, SAT1/SUD/3/76, demonstrated high sequence similarity, based on the complete P1-coding region, with West African isolates, e.g. SAT1/NIG/05/81, indicating historical spread of the disease between East and West Africa. Using a 16 % nt difference cut-off value (Bastos et al., 2003b) , seven of eight previously described distinct lineages could be identified within the SAT1 serotype, while nine of the fourteen SAT2 topotypes could be resolved using the P1 phylogeny (Fig. 1) . Within the southern African region, Zimbabwe shared different SAT1 (1, 2 and 3) and SAT2 topotypes (I, II and III) with neighbouring countries. This correlates well with phylogeny based on the 1D sequence only (data not shown). P1 phylogeny did not provide significantly more resolution for epidemiology purposes, although stronger bootstrap values were observed. An exception was the Angolan SAT2 isolate, ANG/4/74, which grouped separately from other Southern African SAT2 isolates according to 1D phylogeny and was previously assigned to a different topotype (Bastos et al., 2003b; Sangaré et al., 2004) . However, using complete capsid sequence data (Fig. 1) , this isolate was more closely related to the other South African isolates with good bootstrap support.
The intratypic nucleotide variation of the P1 region for SAT1, 2 and 3 was calculated to be 47.3 (n520), 48.9 (n523) and 39.5 % (n55), respectively, and found to be considerably higher than the intratypic variation reported previously for types A, O and C (,18 %) (van Rensburg & Nel, 1999; Knowles & Samuel, 2003) . The nucleotide and amino acid variation in a complete alignment of the SAT P1-coding region is summarized in The P1-coding region of this isolate is 2217 nt in length and has a 6 nt deletion in the 1C-coding region and a 3 nt insertion in 1D. The five SAT3 isolates revealed the most variation in sequence length of the P1 region, ranging from 2214 to 2223 nt and encoding a polypeptide of between 738 and 741 aa in length. The maximum number of nucleotide differences observed intratypically in any pairwise alignment of the P1 regions of isolates within SAT1, SAT2 and SAT3 serotypes was 581 (26.1 %), 558 (25.1 %) and 617 (27.74 %), respectively. The average proportion of nucleotide differences was estimated to be 53.6, 55.7 and 57 % over synonymous sites, and 9.4, 9.2 and 11.2 % over non-synonymous sites for the three serotypes, respectively. Therefore, our data suggests an overall ratio of synonymous : non-synonymous changes to be approximately 6 : 1 for SAT 1, 2 and 3.
Analysis of antigenic properties of SAT1 and SAT2 viruses
One-way antigenic relationships (r 1 -values) were used to compare SAT1 and SAT2 viruses from various topotypes in sub-Saharan Africa to select reference strains within each serotype. Since SAT3 viruses has the most restricted distribution and are the least frequently recovered from buffalo (Bastos et al., 2003b ) these isolates were not included in this study. The virus isolates and the mean r 1 -values are summarized in Tables 2 and 3 . Sera from cattle vaccinated twice with the two SAT1 viruses, SAR/09/81 and KNP/196/91, both belonging to topotype 1, demonstrated r 1 -values that were higher with isolates belonging to the same topotype compared with isolates from other topotypes. Among the 20 SAT1 isolates analysed against the vaccine strains, 15 (n53) and 15 % (n53) showed Fig. 1 . Minimum evolution tree depicting the gene relationships for the P1-coding regions, respectively, of SAT1, 2 and 3 viruses from South (Kruger National Park, KNP; South Africa, SAR; Zimbabwe, ZIM; Rhodesia, RHO; Mozambique, MOZ; Namibia, NAM; Zambia, ZAM; and Angola, ANG), West (Nigeria, NIG; Senekal, SEN; and Ghana, GHA) and East Africa (Uganda, UGA; Rwanda, RWA; Zaire, ZAI; Kenya, KEN; Tanzania, TAN; Eritrea, ERI; Saudi Arabia, SAU and Sudan, SUD). The major topotypes for SAT1 (labelled 1-8), SAT2 (labelled I-XII) and SAT3 (I-VI) viruses are indicated. No representative isolates of SAT1 topotype 6 and of SAT2 topotypes III, IV, X, XIII and XIV were included. Bootstrap support ¢65 is based on a 1000 replicates and is indicated next to the relevant node. (Table  2) . Furthermore, 55 (n511) and 70 % (n514) of the isolates had r 1 -values in the range from 0.2 to 0.39, indicating that a high potency vaccine may still afford protection in animals. The remaining isolates reacted poorly to antisera directed against these vaccine strains, indicating that the vaccines will most probably not protect animals in the field against these strains. Convalescent sera to a West African SAT1 virus, i.e. SAT1/NIG/05/81, showed reasonable cross-protection (r 1 -values of 0.2-0.39) against 75 % (n515) of the SAT1 viruses (Table 2 ). Only one isolate had an r 1 -value of ¢0.4, i.e. SUD/3/76, which belongs to the same topotype as the Nigerian isolate. The difference in cross-reaction with the reference sera might be indicative of differences in shared epitopes of the isolate in question to the reference virus.
The SAT2 reference antisera used in the study were from the SAT2 vaccine strains ZIM/07/83 and KNP/19/89 that belong to SAT2 topotypes I and II, respectively, and two convalescent antisera, that of ERI/12/89 and RWA/02/01 from topotypes VII and VIII, respectively (Table 3 ). The antigenic variation for the SAT2 isolates was more pronounced compared with SAT1 isolates, with r 1 -values below 0.2 even when vaccine and field strains from the same topotype were compared. With the exception of the reaction of the ZIM/07/83 isolate to the KNP/19/89 sera, none of the other SAT2 isolates showed r 1 -values in the range of 0.4-1.0 against any of the four reference strains. Although none of the SAT2 isolates had r 1 -values of 0.2-0.39 against ZIM/7/83 antisera, at least 16.6 % (n54) of the isolates fell into this range using KNP/19/89 antisera. Furthermore, 28 and 25 % (n56 and n55) of isolates had r 1 -values of 0.2-0.39 when tested against ERI/12/89 and RWA/02/01 antisera, respectively. From the data in Table 3 the convalescent sera (ERI/12/89 and RWA/02/01) appear to be more cross-reactive than the sera derived from the immunized animals (ZIM/07/83 and KNP19/89). However, the best consensus estimate model described by Reeve et al. (2010) did not show a difference for sera prepared by vaccination or collected from infected animals.
Comparison of amino acid variation within the SAT1 and 2 serotypes
We extended our study to investigate potential regions involved in the antigenic variability of SAT1 and SAT2 viruses based on the identification of hypervariable regions and positions of high entropy in the capsid-coding regions for SAT viruses. Hypervariable regions, in which 60 % or more of the residue positions varied (using overlapping windows of 10 aa), were identified in the outer capsid proteins, i.e. 1B, 1C and 1D (see Supplementary material, available in JGV Online). Within hypervariable regions, entropy was used to measure the uncertainty at each amino acid position within the SAT alignment (Schneider & Stephens, 1990) . Interestingly, differences were observed DThe number of variant nucleotides or amino acids for each genomic region or capsid protein relative to the total number of positions was used to estimate the percentage (%) variability.
between hypervariable sites for SAT1 and 2 isolates obtained from eastern, western and southern Africa. The hydrophilicity and deduced surface exposure were also considered for each residue and highly variable regions correlated with regions of significant hydrophilicity (see Supplementary material). Comparison of the P1 amino acid sequences of SAT1 and 2 with type A and O sequences, revealed that many of the SAT1 and 2 hypervariable regions corresponded or were located in close proximity to previously identified immuno-dominant sites on types O and A (Table 4 ; Xie et al., 1987; Thomas et al., 1988; Baxt et al., 1989; Bolwell et al., 1989; McCahon et al., 1989; Kitson et al., 1990; Saiz et al., 1991; Crowther et al., 1993a) . Some hypervariable regions were located within flexible structural loops or downstream of protease cleavage sites.
As expected, the internally located 1A protein was the most conserved of the structural proteins with only 27 % variable positions on amino acid level (only 6 % identified as parsimony-informative) between SAT1 and SAT2 ( Predicting antigenic sites on FMDV capsid of SAT bB-bC and bE-bF loops have significant surface exposure in the complete virion, while the N terminus of 1B (bA-bB loop) is located on the inner surface of the capsid in close proximity with the N terminus of 1D.
The 1C protein varied from 221 to 222 aa in length for SAT1 and SAT2 isolates, respectively. The exception was a SAT2 isolate from West Africa, SEN/7/83, which was only 220 aa in length. For 1C, the overall variable amino acid positions was 65 % (37 % variation within SAT1 and 30 % within SAT2) ( Table 1 ). The genetic heterogeneity of 1C was confined to four hypervariable regions (Table 4) , i.e. N terminus (aa 30-45), bB-bC loop (aa 63-77), bE-bF loop (aa 125-142) and bG-bH loop (aa 165-183/172). The heterogeneity was more pronounced in SAT1 viruses with some unique amino acids confined to different topotypes. The latter three of these hypervariable regions (consisting of the bB-bC, bE-bF and bG-bH loops) correlated with hydrophilic surface-exposed regions, indicating its possible contribution to antigenic determinants (see Supplementary material).
The 1D protein, the most variable of the outer capsid proteins, varied in length from 213 aa for SAT2 to 219 aa for SAT1 with 71 % overall variable amino acid positions (48 % within SAT1 and 50 % within SAT2) ( Table 4 . A summary of the hypervariable regions observed in an alignment of the amino acid sequences of SAT1 and two outer capsid proteins
The hypervariable regions were considered in relation with structurally exposed loops and with known antigenic sites in serotype A and O sequences. *Residues within the starred regions have significant surface exposure (Fig. 2) and entropy that could contribute to the changes in antigenicity observed.
Amino acid hypervariable regionD
Capsid secondary structure elements
b-Sheets (Table 4) . These regions corresponded with the N terminus (residues 9-40 in SAT viruses), bB-bC loop (residues 43-62/71 for SAT1 and 2), bE-bF loop (residues 80-103), bF-bG loop (residues 110-122), bG-bH loop (residues 136-167), bH-bI loop (residues 176-187) and the C terminus (residues 199-220/192-212 for SAT1 and 2). With the exception of the N terminus and bF-bG loop, the hypervariable regions coincided with hydrophilic surface-exposed regions.
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Amino acid residues situated within regions of hypervariability in the outer capsid proteins, which exhibit high entropy and hydrophilicity, and on structurally exposed loops were regarded as having the potential for involvement in antibody recognition sites. These regions are therefore possibly involved in the antigenicity of the virion (Table 4 and Supplementary material).
Amino acid changes and antigenic types within the SAT serotypes
To obtain information regarding the relationship between genetic distance and mean r 1 -values for SAT1 and SAT2 viruses, the mean r 1 -values obtained for each field isolate against the reference sera were plotted against the total amino acid changes between the field strain and reference virus ( Supplementary Fig. S1 , available in JGV Online). For SAT1 viruses, a close genetic relationship with the reference strain, as observed by considerable amino acid identity, did agree with sufficient serological cross-reaction. However, for the SAT2 viruses the observed r 1 -values were low, even for viruses with considerable identity with the reference strain. The availability of the deduced amino acid sequences for the P1 regions of the VNT analysed viruses allows for the direct comparison of amino acid residue changes between any two isolates. In addition, residues located in hypervariable regions that are surface-exposed can be identified and counted between any two sequences. The changes specifically corresponding to surface-exposed residues are expected to correlate directly with antigenic variability as it may abrogate antibody binding and neutralization in vitro. This can be explained using two examples, one for SAT1 and SAT2, respectively.
In a pairwise alignment of the P1 polypeptide of the SAT1/ SAR/9/81 virus and five additional topotype 1 isolates (KNP/196/91, KNP148/91, KNP/41/95, ZIM/GN/13/91 and ZIM/HV/03/90), 17 to 55 variable amino acids were observed ( Table 2 ). The r 1 -values for these viruses varied from 0.22 to 0.45, indicating poor but some cross-reaction to good cross-reaction (Table 2 and Supplementary Fig.  S1 ). Since the outer-capsid protein surface-exposed residues are directly involved in antigenicity (Logan et al., 1993; Lea et al., 1995) (Table 3 and Supplementary Fig. S1b ). These 16 variable residues are likely involved in abolishing the neutralization by SAT2/KNP/19/ 89 antisera. Using structural data, surface-exposed residues with high entropy could be identified in the bE-bF (aa 130-134) loop of 1B, the bE-bF (aa 129-134) loop of 1C, and bB-bC (aa 63-68), bE-bF (aa 83-85), bF-bG (aa 110-112), bG-bH (aa 136-140 and 156-161), bH-bI (aa 172-176) and C terminus (aa 200-202) of 1D.
Taken together the inability of anti-SAT1/SAR/09/81 or anti-SAT2/KNP/19/89 antiserum from vaccinated animals to neutralize genetically related viruses may be the result of amino acid variation in the above-mentioned surfaceexposed b-loops.
Mapping putative antigenic sites on the virus capsid
We modelled the SAT1 and SAT2 capsid structures using O 1 BFS (Logan et al., 1993) as template. The model was based on the optimal alignment of the SAT1 virus, SAR/09/ 81, or the SAT2 virus, ZIM/07/83, P1 sequences to the corresponding sequence of O 1 BFS. The homology modelled structure was calculated by the satisfaction of spatial restraints as described by empirical databases. Using this method and mapping the observed variable loops (Table 4) to the structures, we identified several putative antigenic sites on the virus capsid (Fig. 2a, b) . In particular, we observed differences between serotypes, but also within topotypes in a given serotype.
Taking all the topotype information into consideration, the variable residues (high entropy) within surface-exposed loops were regarded as immune relevant and were mapped to the SAT1 and SAT2 pentamer structures, respectively (Fig. 2a, b and Table 4 ). For both serotypes the variable regions outside the 1D bG-bH loop were concentrated around the fivefold and threefold axis of the virion and the C-terminal of 1D. These regions correlated strongly with previously identified neutralizing epitopes of types A and O (Table 4 ). The role of these residues as antigenic determinants can therefore not be excluded. Furthermore, it can be hypothesized that some of the putative epitope regions are probably discontinuous. The close proximity of 1B residues 71-74, 133-134 and 196 or 1B residues 71-74, 196 and 1C residues 64-68 around the threefold axis of the virion or 1D residues 46-49, 84-86 and 177-179 around the fivefold axis of SAT1 viruses are examples (Fig. 2a, b) .
DISCUSSION
This study reports on a genetic and phylogenetic analysis of the entire capsid-coding region and its deduced amino acid sequence of the three SAT serotypes of FMDV. We have also consolidated amino acid variation and r 1 -values with structural data in order to predict areas on the surface of the FMD virion that are antigenically significant.
Based on the complete P1-coding region the phylogeny of 48 SAT isolates with diverse geographical distribution in Africa revealed the same evolutionary lineages within a serotype as previously described for 1D phylogeny (Bastos et al., 2001 (Bastos et al., , 2003a . Phylogenetic analysis of the complete P1-or 1B-and 1C-coding regions of the SAT isolates indicated similar tree topologies compared to 1D phylogeny (data not shown). Phylogeny, based only on the internally located 1A genomic region, revealed similar structuring than that described previously for the Leader and 3C protease-coding regions (van Rensburg et al., 2002) , although different from the outer capsid-coding regions. Darwinian selective pressure for the evolution of the non-structural proteins and the internally located 1A, exist to preserve structure and functionality and escape from immune response is less important (van Rensburg et al., 2002) .
High levels of genetic diversity in the P1-coding region within the SAT serotypes are reflected antigenically and therefore have implications for the control of the disease through vaccination. Antigenic analysis of field isolates in relation to vaccine strains, based on VNTs, play a significant role in evaluating the suitability of existing vaccine strains (Jangra et al., 2005; Paton et al., 2005; Brehm et al., 2008) , despite significant variation having been reported with VNTs (Rweyemamu et al., 1978 (Rweyemamu et al., , 1984 . It is generally accepted that r 1 -values higher than 0.4 demonstrates a good cross-protection of the vaccine against the field isolate (Samuel et al., 1990) . Although SAT1 and SAT2 viruses displayed a similar number of variable amino acids (32 %) in a complete alignment, antigenic variation within SAT1 was less pronounced (73 % of r 1 -values .0.2) than for SAT2 viruses (17 % of r 1 -values .0.2) within the dataset. The implication for control by vaccination is that a high potency or bi-valent SAT1 vaccine will most likely be effective across topotypes. Indeed, it has been shown for serotype A viruses that a high potency vaccine provides protection against heterologous challenge despite low r 1 -values (Brehm et al., 2008) . Better antigenic relationships were obtained for the SAT1 viruses belonging to the same topotype of the reference viruses (with less than 16 % aa variation). In the past, the combination of SAT1/SAR/9/81 and SAT1/KNP/196/91 in a tetravalent vaccine, containing also a SAT2 and a SAT3 strain, were able to protect against SAT1 outbreaks in Southern Africa (Hunter, 1998 (Ndiritu et al., 1983) . The poor antigenic coverage of existing vaccine strains against field strains call for urgent development of multiple regionspecific or topotype-specific vaccine strains. Additionally, there is a need for a SAT2 vaccine strain that will provide protection against a wide range of antigenic types in the field.
mAbs against FMDV were used in the past to identify antigenic variants and to resolve epitopes that play a role in the neutralization of the virus. The majority of these mAbs were against Euro-Asian serotypes A, O and C (Xie et al., 1987; Thomas et al., 1988; Baxt et al., 1989; Bolwell et al., 1989; McCahon et al., 1989; Kitson et al., 1990; Saiz et al., 1991; Crowther et al., 1993a) . Only one report described the mapping of epitopes to a SAT2 virus (RHO/1/48) isolated in 1948 (Crowther et al., 1993b) , with residues 147-149 and 156 in the flexible and surface-exposed G-H loop of 1D proven to be important in in vitro neutralization by a mAb.
We followed a different approach by combining amino acid variation and calculated r 1 -values from in vitro crossprotection titres in VNTs, together with structural data, to predict areas on the surface of the capsid as antigenically relevant. This modelling approach has identified putative antigenic regions that correlated with cross-neutralization in vitro for the SAT1 and SAT2 serotypes, and may contain neutralizing epitopes for each serotype. These antigenic sites were consistent within, but not between serotypes, and were found to match some of the mAbs identified antigenic sites in other serotypes. These are the hypervariable, surface-exposed structural loops observed for SAT1 or SAT2 viruses, i.e. bB-bC and bE-bF loops of 1B, the bBbC and bE-bF loops of 1C, and the N-terminal, bB-bC, bG-bH, bH-bI loops and C-terminal of 1D. The antigenic sites for SAT2 viruses differed by having no significant variation within the bB-bC loop of 1C, but with additional variation in the bD-bE and bF-bG loops of 1D. Epitopes identified from mAb escape mutants for other serotypes confirms the immune relevance of these structural loops.
The bB-bC, bE-bF and bH-bI loops of 1B contains site 2 of serotype O (Kitson et al., 1990; Crowther et al., 1993a) , site 3 on A10 (Thomas et al., 1988) and bB-bC also correlates with subsite D2 on C . The bB-bC loop of 1C is in agreement with site 3 on A10 (Thomas et al., 1988) , while bB-bC, bG-bH, bH-bI loops and C-terminal of 1D all agree with epitopes identified for serotypes A, O and C (Kitson et al., 1990; Crowther et al., 1993a; Thomas et al., 1988; Mateu et al., 1995) .
Although the putative antigenic sites need to be confirmed using mAbs and sequencing of virus escape mutants, the methodology employed in this study offers a potentially quick, easy and cheap alternative to the identification of antigenic relevant sites on field FMD strains. The Leader-P1-2A-coding regions of the isolates were obtained via RT-PCR of viral genomic RNA as described previously (Bastos, 1998; van Rensburg et al. 2002) . Direct DNA sequencing of amplicons yielded a consensus sequence representing the most probable nucleotide for each position. Sequences of the approximately 2.2 kb P1-coding region were compiled and edited using the BioEdit 5.0.9 software (Hall, 1999) . The nucleotide and deduced amino acid sequences were aligned using CLUSTAL_X (Thompson et al., 1997) and phylogenetic trees constructed using the minimum evolution algorithm within MEGA4 software (Tamura et al., 2007) . Entropy plots were drawn from the deduced amino acid alignments using the BioEdit 5.0.9 software (Hall, 1999) .
METHODS
Animal sera and VNT. The antigenic diversity of the field isolates was determined using cross-neutralization assays in microtitre plates on IB-RS-2 cells, carried out as described by the OIE (2009 The end-point titre of the serum against homologous and heterologous viruses was calculated as the reciprocal of the last dilution of serum to neutralize 100 TCID 50 in 50 % of the wells (Rweyemamu et al., 1978) . All neutralization titre determinations were repeated at least twice, each time using sera from two animals. One-way antigenic relationships (r 1 -value) of the field isolates and vaccine viruses relative to the reference strains were calculated as the ratio between the heterologous and homologous serum titres and were interpreted as proposed by Samuel et al. (1990) . Briefly, r 1 -values between 0 and 0.19 indicated highly significant antigenic variation from the reference strains; values of 0.20-0.39 showed antigenic relatedness where some protection may be provided by a potent vaccine based on the reference strain; and values of 0.40-1.0 demonstrated that the reference and field strains are sufficiently antigenically similar for the reference strain to provide good protection. The means of the r 1 -values were calculated (Tables 1  and 2 ) and plotted against total amino acid changes between the field strains and reference viruses.
Structural modelling. Homology models of the capsid proteins of SAT1 and SAT2 were built using Modeller 9v3 (Sali & Blundell, 1993) with O 1 BFS coordinates (1FOD) as template (Logan et al., 1993) , alignments were performed with CLUSTAL_X and modelling scripts were generated with the structural module of FunGIMS. Structures were visualized and the surface-exposed residues identified with PyMol v1.1rc2pre (DeLano Scientific LLC).
